Loading organizations...
§ Private Profile · Boston, MA, USA
Rhino Health is a company.
Rhino Health has raised $27.0M across 3 funding rounds.
Key people at Rhino Health.
Rhino Health has raised $27.0M in total across 3 funding rounds.
Rhino Health provides a federated computing platform designed to enable secure artificial intelligence development and analytics across decentralized data sources. The company’s core offering facilitates collaborative data analysis and machine learning without requiring the transfer of sensitive raw data, maintaining stringent security, privacy, and sovereignty for its users. This technical approach allows organizations to unlock insights from previously siloed information.
The company was co-founded by Dr. Ittai Dayan, who serves as CEO, and Yuval Baror, the CTO. Their foundational insight stemmed from the critical challenge of disparate and inaccessible data, particularly within healthcare AI. Recognizing that valuable data often remains locked away due to privacy and regulatory concerns, they established Rhino Health to create a framework that allows AI models to learn from distributed datasets securely.
Rhino Health serves clients across industries including healthcare, life sciences, the public sector, and financial services, where data privacy and security are paramount. The company's vision is to accelerate innovation by enabling widespread access to a greater breadth of data for AI development and analytics, fostering cross-organizational collaboration while ensuring that data integrity and governance are never compromised.
Rhino Health has raised $27.0M in total across 3 funding rounds.
Rhino Health's investors include Alexi Nazem, Fusion Fund, Frank Sica, Arkin Digital Health, Gaingels, LionBird, Qiming Venture Partners USA, TELUS Ventures, Wilson's Bird Capital, Arkin Holdings.
Rhino Health has raised $27.0M across 3 funding rounds. Most recently, it raised $15.0M Rhino Federated Computing - Series A in May 2025.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| May 1, 2025 | $15M Series A | Alexi Nazem | Fusion Fund, Frank Sica, Arkin Digital Health, Gaingels, LionBird, Qiming Venture Partners USA, TELUS Ventures, Wilson's Bird Capital | Announced |
| Aug 1, 2022 | $7M Seed | — | Fusion Fund | Announced |
| Feb 10, 2021 | $5M Seed | LionBird | Arkin Holdings | Announced |
Key people at Rhino Health.
Rhino Health is a Boston-based portfolio company that builds the Rhino Federated Computing Platform (Rhino FCP), a distributed compute platform using federated learning and edge computing to enable AI developers, medical researchers, and data scientists to collaborate on diverse datasets without sharing or moving sensitive data.[1][2][3][4] It primarily serves healthcare organizations, life sciences companies, public health agencies, and expanding sectors like financial services, solving the core problem of data fragmentation, privacy risks, and regulatory hurdles that block AI model training on real-world, heterogeneous patient data.[2][3][4][5] The platform powers applications in diagnostics, drug discovery, disease prediction, and public health surveillance, with over 50 hospitals and organizations onboard, $14 million raised, revenue generation, and rapid growth including 20+ healthcare installs and paying industry customers.[1][5]
Rhino Health was co-founded in early 2021 by Dr. Ittai Dayan, a physician and AI researcher who led the EXAM study—a global federated learning project at Mass General Brigham partnering with Nvidia and 20 institutions to predict COVID-19 progression—and Yuval Baror, an experienced AI entrepreneur.[1][2] The idea emerged from Dayan's realization during the EXAM study that AI's potential in healthcare required a streamlined "Federated Computing" platform combining edge computing and federated learning to simplify secure data collaborations.[1][2] Pivotal early traction included launching with a network of leading academic hospitals, forming the Federated Learning for Medicine (FL4M) consortium with seven global institutions across four continents in 2022 to improve brain aneurysm detection AI, and expanding to over 50 sites while securing initial paying customers.[3][5]
Rhino Health rides the federated learning and responsible AI trend, addressing exploding demand for AI trained on diverse, real-world data amid strict privacy regs like GDPR/HIPAA and rising health equity needs.[1][2][4] Timing is ideal post-COVID, as fragmented healthcare data (e.g., from global pandemics) highlighted collaboration gaps, while AI hardware advances and edge computing mature to make federated models scalable.[1][3] Market tailwinds include value-based care (VBHC) pushing outcomes transparency, biopharma's need for real-world evidence, and a $TAM spanning every hospital and data science team worldwide for diagnostics, personalized medicine, and public health.[1][4] Rhino influences the ecosystem by pioneering Federated Computing as a category, powering consortia like FL4M/ICHOM, and enabling underrepresented regions' participation in global research—accelerating diverse AI that generalizes across populations.[3][5]
Rhino Health is positioned to dominate as the standard platform for secure data collaborations, scaling its network to hundreds of global hospitals, industry partners (biopharma/medtech), and sectors like finance via Rhino FCP integrations.[1][2][4] Key trends shaping its path: generative AI for data harmonization, VBHC-driven outcomes networks, and sovereign AI mandates favoring on-site computation.[4] Influence could evolve into a "tidal wave" of value—unlocking personalized medicine and proactive public health—potentially via massive network effects and acquisitions, building on its post-2021 momentum from EXAM to 50+ sites.[1][5] This mirrors how early data platforms catalyzed AI booms, priming Rhino to activate "the world's health data" responsibly.[4]
